Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California.
Corresponding author: Meryl M. Sperling, MD, MA, Center for Academic Medicine, Department of Obstetrics and Gynecology, Palo Alto, CA; email: [email protected].
This work was supported by pilot funding from the Stanford Diabetes Research Center (P30DK116074 – 1/1/2021–12/31/2021) as well as by funding from the Stanford University School of Medicine - Division of Maternal-Fetal Medicine. The Stanford REDCap platform (http://redcap.stanford.edu) is developed and operated by Stanford Medicine Research IT team. The REDCap platform services at Stanford are subsidized by a) Stanford School of Medicine Research Office, and b) the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 TR001085.
Financial Disclosure The authors did not report any potential conflicts of interest.
Presented at the Society for Maternal-Fetal Medicine’s 42nd Annual Pregnancy Meeting, held virtually, January 31–February 5, 2022.
The authors thank Mira Diwan, Anna Girsen, and Imee Datoc for assisting with recruitment, ensuring adherence to protocol, and data collection.
Each author has confirmed compliance with the journal's requirements for authorship.
Peer reviews and author correspondence are available at https://links.lww.com/AOG/C964.
